Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 31751-31800 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT06222710
Ultrasound Guiding Pharmacopuncture Therapy for Supraspinatus Tendinopathy
NARecruiting
40 participants
Started: Dec 20, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06486649
Application of Multimodal Large Language Model in HFpEF
N/ARecruiting
80 participants
Started: Dec 20, 2023 · Completed: Dec 20, 2024
1 condition5 sponsors1 location
NCT06155513
Omega-3 Monoglyceride Based Topic Products as Skin Prebiotics for Eczema
NARecruiting
16 participants
Started: Dec 20, 2023 · Completed: May 1, 2025
1 condition2 sponsors1 location
NCT06345014
The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome
PHASE4Recruiting
332 participants
Started: Dec 20, 2023 · Completed: Mar 30, 2026
3 conditions2 sponsors1 location
NCT06105736
Regulating Together in Tuberous Sclerosis Complex
NARecruiting
105 participants
Started: Dec 20, 2023 · Completed: Dec 20, 2026
2 conditions2 sponsors2 locations
NCT06825039
The Effects of Extracorporeal Shock Wave Therapy in Postsurgical Scars Especially After Abdominplasty and Breast Reduction.
NARecruiting
150 participants
Started: Dec 20, 2023 · Completed: Feb 28, 2027
2 conditions5 sponsors4 locations
NCT06154252
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
PHASE1/PHASE2Recruiting
24 participants
Started: Dec 20, 2023 · Completed: Jul 31, 2028
8 conditions1 sponsor25 locations
NCT05679518
Managing Fear of Cancer Progression Metacognition-based Vs Supportive-expressive Based Approaches
NARecruiting
261 participants
Started: Dec 20, 2023 · Completed: Jun 30, 2026
5 conditions2 sponsors4 locations
NCT06021158
A Trial to Compare Automated Lyumjev Delivery With Carbohydrate Counting, Qualitative Meal-size Estimation, and Meal Detection in Type 1 Diabetes
PHASE2Recruiting
12 participants
Started: Dec 20, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06761651
A Study of TAVO412 in Patients with Cancer (TAVO412)
PHASE1Recruiting
50 participants
Started: Dec 20, 2023 · Completed: Oct 15, 2026
1 condition1 sponsor6 locations
NCT06104566
Global Trial in APG2575 for Patients With CLL/SLL
PHASE3Recruiting
400 participants
Started: Dec 20, 2023 · Completed: Oct 31, 2027
1 condition1 sponsor2 locations
NCT06134557
Therapeutic Effect of Blood Flow Reconstruction in IVADA
N/ARecruiting
200 participants
Started: Dec 20, 2023 · Completed: Feb 28, 2024
1 condition1 sponsor1 location
NCT06118086
Study of REM-422 in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
PHASE1Recruiting
65 participants
Started: Dec 20, 2023 · Completed: Jun 1, 2027
3 conditions1 sponsor8 locations
NCT06208774
Pericapsular Nerve Group Block vs Interscalene Block for Shoulder Arthroscopy
NARecruiting
80 participants
Started: Dec 20, 2023 · Completed: May 30, 2024
4 conditions1 sponsor1 location
NCT05581121
PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer
PHASE3Recruiting
510 participants
Started: Dec 20, 2023 · Completed: Dec 31, 2033
3 conditions11 sponsors26 locations
NCT06252753
Observational Study Protocol: LIVER-R
N/ARecruiting
4,490 participants
Started: Dec 20, 2023 · Completed: Dec 30, 2030
1 condition2 sponsors131 locations
NCT06372288
Theta Burst TMS for Treatment of Methamphetamine Use Disorder
NARecruiting
40 participants
Started: Dec 20, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT06938516
Prospective Observational Study On The Impact Of Nebilet In Blood Pressure Control In Hypertensive Patients (HYIMPACT)
N/ARecruiting
4,537 participants
Started: Dec 20, 2023 · Completed: Mar 31, 2029
1 condition1 sponsor49 locations
NCT05656924
Deploying Digital Prosthetic Interface Technology and Exercise in Dysvascular Amputees
PHASE2Recruiting
38 participants
Started: Dec 20, 2023 · Completed: Dec 31, 2026
2 conditions3 sponsors1 location
NCT06262152
Sleep Profile of Patients With Septo-optic Dysplasia
N/ARecruiting
45 participants
Started: Dec 20, 2023 · Completed: May 20, 2025
3 conditions1 sponsor1 location
NCT05998902
Optimizing Early Nutrition Support in Severe Stroke-2
PHASE3Recruiting
546 participants
Started: Dec 20, 2023 · Completed: Oct 31, 2026
3 conditions21 sponsors30 locations
NCT05564793
Improving CRT Outcome With Non-Invasive Cardiac Mapping
NARecruiting
330 participants
Started: Dec 20, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors11 locations
NCT06142032
Support Groups in the Metaverse for Ukrainian Refugees
NARecruiting
45 participants
Started: Dec 20, 2023 · Completed: Apr 30, 2025
2 conditions1 sponsor1 location
NCT06017609
Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction
PHASE2Recruiting
300 participants
Started: Dec 20, 2023 · Completed: Feb 28, 2027
1 condition2 sponsors75 locations
NCT05912517
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)
PHASE3Recruiting
120 participants
Started: Dec 20, 2023 · Completed: Jul 10, 2029
1 condition1 sponsor56 locations
NCT06150157
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
PHASE1Recruiting
100 participants
Started: Dec 20, 2023 · Completed: Dec 15, 2027
4 conditions1 sponsor26 locations
NCT06058013
Study to Assess the Effects of Oral NMRA-335140 Versus Placebo in Participants With Major Depressive Disorder
PHASE3Recruiting
332 participants
Started: Dec 20, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor71 locations
NCT05931393
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
PHASE2Recruiting
18 participants
Started: Dec 20, 2023 · Completed: Dec 31, 2028
2 conditions2 sponsors1 location
NCT06214507
Danon Disease Natural History Study
N/ARecruiting
46 participants
Started: Dec 20, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor13 locations
NCT05718323
Niraparib Added to Anti-PD-L1 Antibody Maintenance in SLFN11-positive, Extensive-disease SCLC
PHASE2Recruiting
44 participants
Started: Dec 20, 2023 · Completed: Jun 30, 2026
2 conditions3 sponsors18 locations
NCT06283446
Enhancing Prospective Thinking in Early Recovery (NERF)
NARecruiting
98 participants
Started: Dec 20, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05934682
Latin American Surgical Outcomes Study in Pediatric Patients
N/ARecruiting
10,000 participants
Started: Dec 20, 2023 · Completed: Mar 30, 2025
5 conditions1 sponsor1 location
NCT06173817
The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients
PHASE2/PHASE3Recruiting
30 participants
Started: Dec 20, 2023 · Completed: Jun 30, 2026
1 condition6 sponsors1 location
NCT05416125
Vyvanse in Children Aged 6 to 12 Years
EARLY_PHASE1Recruiting
40 participants
Started: Dec 20, 2023 · Completed: Nov 30, 2029
1 condition1 sponsor1 location
NCT06096181
Propofol + Remifentanil vs. Propofol + Dexmedetomidine in Adolescent Idiopathic Scoliosis Patients Having Spine Surgery
PHASE2Recruiting
120 participants
Started: Dec 20, 2023 · Completed: Jun 30, 2028
6 conditions1 sponsor1 location
NCT06201130
Airway Microbiome Changes After Artificial Airway Exchange in Critically-ill Pediatric Patients.
N/ARecruiting
50 participants
Started: Dec 20, 2023 · Completed: Jun 26, 2025
7 conditions1 sponsor1 location
NCT06143436
TCM Constitution, Pattern Types, and Disease Factors in Primary Lung Cancer.
N/ARecruiting
250 participants
Started: Dec 20, 2023 · Completed: May 19, 2025
4 conditions1 sponsor1 location
NCT06100705
Sipuleucel-T Combined with Bipolar Androgen Therapy in Men with MCRPC
PHASE2Recruiting
26 participants
Started: Dec 20, 2023 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT05995782
A Phase 1, SAD and MAD Study to Evaluate the Safety and Tolerability of FB418
PHASE1Recruiting
64 participants
Started: Dec 20, 2023 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT06413303
The Effect of Experiential Classroom on Establishing Healthy Behaviors During Pregnancy
NARecruiting
136 participants
Started: Dec 20, 2023 · Completed: May 31, 2025
4 conditions1 sponsor1 location
NCT06117683
Non-inferiority Trial Between Sotair® Device Attached to Manual Resuscitator Versus Mechanical Ventilation
NARecruiting
310 participants
Started: Dec 20, 2023 · Completed: Jul 31, 2025
2 conditions1 sponsor1 location
NCT06356376
The Effects of Pain and Pain Relief on Peripheral Nerve Excitability
N/ARecruiting
30 participants
Started: Dec 20, 2023 · Completed: Apr 30, 2024
1 condition2 sponsors1 location
NCT06263348
A Post-Marketing Safety Study of Dorzagliatin in Patients With Type 2 Diabetes
PHASE4Recruiting
2,000 participants
Started: Dec 20, 2023 · Completed: Apr 30, 2026
1 condition2 sponsors2 locations
NCT05745844
Evaluation of Neuromuscular ElectroStimulation in Addition to a Physical Activity Program
NARecruiting
48 participants
Started: Dec 20, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors1 location
NCT05948475
Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma
PHASE3Recruiting
200 participants
Started: Dec 20, 2023 · Completed: Aug 31, 2026
1 condition1 sponsor87 locations
NCT06046222
Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyangiitis
PHASE2Recruiting
45 participants
Started: Dec 20, 2023 · Completed: Jul 31, 2026
2 conditions2 sponsors34 locations
NCT05874479
Reducing AIR Pollution Exposure to Lower Blood PRESSURE Among New York City Public Housing Residents
NARecruiting
440 participants
Started: Dec 20, 2023 · Completed: Mar 31, 2028
1 condition2 sponsors1 location
NCT06167694
Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer
PHASE1/PHASE2Recruiting
146 participants
Started: Dec 20, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06223659
EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers
PHASE2Recruiting
100 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2025
3 conditions1 sponsor1 location
NCT06190665
DEB-TACE With Visualable Microspheres Versus PVA Microspheres for HCC
NARecruiting
188 participants
Started: Dec 19, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations